| MeSH term | MeSH ID | Detail |
|---|---|---|
| Pain | D010146 | 64 associated lipids |
| Lung Diseases | D008171 | 37 associated lipids |
| Burns | D002056 | 34 associated lipids |
| Inflammation | D007249 | 119 associated lipids |
| Colitis | D003092 | 69 associated lipids |
| Fatty Liver | D005234 | 48 associated lipids |
| Pain, Postoperative | D010149 | 13 associated lipids |
| Peritonitis | D010538 | 38 associated lipids |
| Alzheimer Disease | D000544 | 76 associated lipids |
| Uveitis | D014605 | 14 associated lipids |
Resolvin d1
Resolvin d1 is a lipid of Fatty Acyls (FA) class.
Cross Reference
There are no associated biomedical information in the current reference collection.
Current reference collection contains 305 references associated with Resolvin d1 in LipidPedia. Due to lack of full text of references or no associated biomedical terms are recognized in our current text-mining method, we cannot extract any biomedical terms related to diseases, pathways, locations, functions, genes, lipids, and animal models from the associated reference collection.
Users can download the reference list at the bottom of this page and read the reference manually to find out biomedical information.
Here are additional resources we collected from PubChem and MeSH for Resolvin d1
Possible diseases from mapped MeSH terms on references
We collected disease MeSH terms mapped to the references associated with Resolvin d1
PubChem Biomolecular Interactions and Pathways
All references with Resolvin d1
Download all related citations| Authors | Title | Published | Journal | PubMed Link |
|---|---|---|---|---|
| Lee Y et al. | Analysis of endogenous lipids during intestinal wound healing. | 2017 | PLoS ONE | pmid:28800645 |
| Lippestad M et al. | Resolvin D1 Increases Mucin Secretion in Cultured Rat Conjunctival Goblet Cells via Multiple Signaling Pathways. | 2017 | Invest. Ophthalmol. Vis. Sci. | pmid:28892824 |
| Mottola G et al. | Aspirin-triggered resolvin D1 attenuates PDGF-induced vascular smooth muscle cell migration via the cyclic adenosine monophosphate/protein kinase A (cAMP/PKA) pathway. | 2017 | PLoS ONE | pmid:28362840 |
| Eickmeier O et al. | Pro-resolving lipid mediator Resolvin D1 serves as a marker of lung disease in cystic fibrosis. | 2017 | PLoS ONE | pmid:28158236 |
| Gu Z et al. | Resolvin D1, resolvin D2 and maresin 1 activate the GSK3β anti-inflammatory axis in TLR4-engaged human monocytes. | 2016 | Innate Immun | pmid:26878867 |
| Xie W et al. | ResolvinD1 reduces apoptosis and inflammation in primary human alveolar epithelial type 2 cells. | 2016 | Lab. Invest. | pmid:26878131 |
| Croasdell A et al. | Resolvin D1 Dampens Pulmonary Inflammation and Promotes Clearance of Nontypeable Haemophilus influenzae. | 2016 | J. Immunol. | pmid:26843331 |
| Liu Y et al. | Resolvin D1 protects against inflammation in experimental acute pancreatitis and associated lung injury. | 2016 | Am. J. Physiol. Gastrointest. Liver Physiol. | pmid:26702138 |
| Abdulnour RE et al. | Aspirin-triggered resolvin D1 is produced during self-resolving gram-negative bacterial pneumonia and regulates host immune responses for the resolution of lung inflammation. | 2016 | Mucosal Immunol | pmid:26647716 |
| Berrueta L et al. | Stretching Impacts Inflammation Resolution in Connective Tissue. | 2016 | J. Cell. Physiol. | pmid:26588184 |
| Kim N et al. | Specialized proresolving mediators (SPMs) inhibit human B-cell IgE production. | 2016 | Eur. J. Immunol. | pmid:26474728 |
| Benabdoune H et al. | The role of resolvin D1 in the regulation of inflammatory and catabolic mediators in osteoarthritis. | 2016 | Inflamm. Res. | pmid:27056390 |
| Meesawatsom P et al. | Inhibitory effects of aspirin-triggered resolvin D1 on spinal nociceptive processing in rat pain models. | 2016 | J Neuroinflammation | pmid:27589850 |
| Easley JT et al. | AT-RvD1 combined with DEX is highly effective in treating TNF-α-mediated disruption of the salivary gland epithelium. | 2016 | Physiol Rep | pmid:27694530 |
| Titos E et al. | Signaling and Immunoresolving Actions of Resolvin D1 in Inflamed Human Visceral Adipose Tissue. | 2016 | J. Immunol. | pmid:27647830 |
| Wang CS et al. | ALX/FPR2 Modulates Anti-Inflammatory Responses in Mouse Submandibular Gland. | 2016 | Sci Rep | pmid:27064029 |
| Luo B et al. | Resolvin D1 Programs Inflammation Resolution by Increasing TGF-β Expression Induced by Dying Cell Clearance in Experimental Autoimmune Neuritis. | 2016 | J. Neurosci. | pmid:27629711 |
| Kim KH et al. | Resolvin D1 prevents smoking-induced emphysema and promotes lung tissue regeneration. | 2016 | Int J Chron Obstruct Pulmon Dis | pmid:27313451 |
| Zhao Q et al. | Resolvin D1 Alleviates the Lung Ischemia Reperfusion Injury via Complement, Immunoglobulin, TLR4, and Inflammatory Factors in Rats. | 2016 | Inflammation | pmid:27145782 |
| Zhao YL et al. | Resolvin D1 Protects Lipopolysaccharide-induced Acute Kidney Injury by Down-regulating Nuclear Factor-kappa B Signal and Inhibiting Apoptosis. | 2016 | Chin. Med. J. | pmid:27098797 |
| Shi H et al. | VIP protects human retinal microvascular endothelial cells against high glucose-induced increases in TNF-α and enhances RvD1. | 2016 | Prostaglandins Other Lipid Mediat. | pmid:27026343 |
| Zhao Q et al. | Resolvin D1 mitigates energy metabolism disorder after ischemia-reperfusion of the rat lung. | 2016 | J Transl Med | pmid:27009328 |
| Schmid M et al. | Resolvin D1 Polarizes Primary Human Macrophages toward a Proresolution Phenotype through GPR32. | 2016 | J. Immunol. | pmid:26969756 |
| Prieto P et al. | Activation of autophagy in macrophages by pro-resolving lipid mediators. | 2015 | Autophagy | pmid:26506892 |
| Lehmann C et al. | Lipoxin and resolvin biosynthesis is dependent on 5-lipoxygenase activating protein. | 2015 | FASEB J. | pmid:26289316 |
| Hsiao HM et al. | Resolvin D1 Reduces Emphysema and Chronic Inflammation. | 2015 | Am. J. Pathol. | pmid:26468975 |
| Maekawa T et al. | Antagonistic effects of IL-17 and D-resolvins on endothelial Del-1 expression through a GSK-3β-C/EBPβ pathway. | 2015 | Nat Commun | pmid:26374165 |
| Taylan A et al. | S1000A12, Chitotriosidase, and Resolvin D1 as Potential Biomarkers of Familial Mediterranean Fever. | 2015 | J. Korean Med. Sci. | pmid:26339162 |
| Cox R et al. | Resolvins Decrease Oxidative Stress Mediated Macrophage and Epithelial Cell Interaction through Decreased Cytokine Secretion. | 2015 | PLoS ONE | pmid:26317859 |
| Croasdell A et al. | Resolvins attenuate inflammation and promote resolution in cigarette smoke-exposed human macrophages. | 2015 | Am. J. Physiol. Lung Cell Mol. Physiol. | pmid:26301452 |
| Rossi S et al. | Interplay between Intravitreal RvD1 and Local Endogenous Sirtuin-1 in the Protection from Endotoxin-Induced Uveitis in Rats. | 2015 | Mediators Inflamm. | pmid:26180376 |
| de Oliveira JR et al. | AT-RvD1 modulates CCL-2 and CXCL-8 production and NF-κB, STAT-6, SOCS1, and SOCS3 expression on bronchial epithelial cells stimulated with IL-4. | 2015 | Biomed Res Int | pmid:26075216 |
| Shevalye H et al. | Effect of enriching the diet with menhaden oil or daily treatment with resolvin D1 on neuropathy in a mouse model of type 2 diabetes. | 2015 | J. Neurophysiol. | pmid:25925322 |
| Kain V et al. | Resolvin D1 activates the inflammation resolving response at splenic and ventricular site following myocardial infarction leading to improved ventricular function. | 2015 | J. Mol. Cell. Cardiol. | pmid:25870158 |
| Fiala M et al. | ω-3 Supplementation increases amyloid-β phagocytosis and resolvin D1 in patients with minor cognitive impairment. | 2015 | FASEB J. | pmid:25805829 |
| Orr SK et al. | Proresolving actions of a new resolvin D1 analog mimetic qualifies as an immunoresolvent. | 2015 | Am. J. Physiol. Lung Cell Mol. Physiol. | pmid:25770181 |
| Dalli J et al. | Novel proresolving and tissue-regenerative resolvin and protectin sulfido-conjugated pathways. | 2015 | FASEB J. | pmid:25713027 |
| Rossi S et al. | Protection from endotoxic uveitis by intravitreal Resolvin D1: involvement of lymphocytes, miRNAs, ubiquitin-proteasome, and M1/M2 macrophages. | 2015 | Mediators Inflamm. | pmid:25684860 |
| Cox R et al. | Enhanced Resolution of Hyperoxic Acute Lung Injury as a result of Aspirin Triggered Resolvin D1 Treatment. | 2015 | Am. J. Respir. Cell Mol. Biol. | pmid:25647402 |
| Lastrucci C et al. | Molecular and cellular profiles of the resolution phase in a damage-associated molecular pattern (DAMP)-mediated peritonitis model and revelation of leukocyte persistence in peritoneal tissues. | 2015 | FASEB J. | pmid:25609430 |
| Pierdomenico AM et al. | MicroRNA-181b regulates ALX/FPR2 receptor expression and proresolution signaling in human macrophages. | 2015 | J. Biol. Chem. | pmid:25505240 |
| Wang X et al. | Resolution of inflammation is altered in Alzheimer's disease. | 2015 | Alzheimers Dement | pmid:24530025 |
| Lim JY et al. | Biological Roles of Resolvins and Related Substances in the Resolution of Pain. | 2015 | Biomed Res Int | pmid:26339646 |
| Hiram R et al. | Resolvin E1 normalizes contractility, Ca2+ sensitivity and smooth muscle cell migration rate in TNF-α- and IL-6-pretreated human pulmonary arteries. | 2015 | Am. J. Physiol. Lung Cell Mol. Physiol. | pmid:26320154 |
| Harrison JL et al. | Resolvins AT-D1 and E1 differentially impact functional outcome, post-traumatic sleep, and microglial activation following diffuse brain injury in the mouse. | 2015 | Brain Behav. Immun. | pmid:25585137 |
| Yaxin W et al. | Resolvin D1 attenuates lipopolysaccharide induced acute lung injury through CXCL-12/CXCR4 pathway. | 2014 | J. Surg. Res. | pmid:24387839 |
| Chen J et al. | Aspirin-triggered resolvin D1 down-regulates inflammatory responses and protects against endotoxin-induced acute kidney injury. | 2014 | Toxicol. Appl. Pharmacol. | pmid:24709673 |
| Nelson JW et al. | ALX/FPR2 receptor for RvD1 is expressed and functional in salivary glands. | 2014 | Am. J. Physiol., Cell Physiol. | pmid:24259417 |
| Rius B et al. | Resolvin D1 primes the resolution process initiated by calorie restriction in obesity-induced steatohepatitis. | 2014 | FASEB J. | pmid:24249635 |
| Chen F et al. | Resolvin D1 improves survival in experimental sepsis through reducing bacterial load and preventing excessive activation of inflammatory response. | 2014 | Eur. J. Clin. Microbiol. Infect. Dis. | pmid:24072678 |